E Rothzerg, J Xu, D Wood - Journal of Molecular Pathology, 2023 - mdpi.com
Osteosarcoma (OS) is a primary malignant bone tumour that usually occurs in children and adolescents. OS is a highly aggressive tumour type with a propensity for local invasion and …
MT de Oliveira Rodrigues, LP da Silva… - … and Biophysics Reports, 2022 - Elsevier
Aims Osteosarcoma (OS) is the most common primary malignant bone sarcoma among children and adolescents. Treatment is based on neo-adjuvant and adjuvant chemotherapy …
W Sirikul, N Buawangpong, D Pruksakorn… - Cancers, 2023 - mdpi.com
Simple Summary Overall survival for osteosarcoma and Ewing's sarcoma has been improved since the introduction of multi-agent chemotherapy. However, there has been …
Y Furui, K Komori, T Kurata, K Sakashita - Cureus, 2023 - ncbi.nlm.nih.gov
Ifosfamide, which is widely used as a chemotherapeutic agent in various kinds of malignancies, sometimes causes neurotoxicity known as ifosfamide-induced …
Background: Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. High-risk NB still has a poor prognosis and requires complex aggressive therapy. For a …
JR Goda, EV Sonata, Š Trakymienė… - Acta medica Lituanica, 2022 - redalyc.org
Hematopoietic stem cell transplantation (HSCT) is a complex procedure that is curative for several fatal pediatric malignancies and non-malignant diseases. Despite its complexity …
K Merkevičius, I Tamulienė… - Acta medica Lituanica …, 2022 - epublications.vu.lt
acta medica lituaNica Page 1 NatioNal caNcer iNstitute the lithuaNiaN academy of scieNces VilNius uNiVersity acta medica lituaNica 2022 Vol. 29, No 2 / Supplement …
MT de Oliveira Rodrigues¹, L Pereira da Silva¹… - Available at SSRN … - papers.ssrn.com
Aims: Osteosarcoma (OS) is the most common primary malignant bone sarcoma among children and adolescents. Treatment is based on neo-adjuvant and adjuvant chemotherapy …